Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Pfizer”
Sponsor: Pfizer
Healthy
Belgium
- Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis PopulationActive Not Recruiting
Sponsor: Pfizer
Ulcerative Colitis
United Kingdom
Sponsor: Pfizer
Breast Neoplasms
China, Hong Kong, Singapore, Taiwan, Thailand
- Thyroid Cancer and SunitinibCompleted
Sponsor: University Hospital, Bordeaux
Cancer · Thyroid Carcinoma
France
Sponsor: Pfizer
Primary Immune Thrombocytopenia
United States, Australia, Canada, Czechia, Hungary +2 more
- Adjuvant Palbociclib in Elderly Patients With Breast CancerActive Not Recruiting
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Breast Cancer Stage II · Breast Cancer Stage III
Belgium, France, Germany, Italy, Jordan +4 more
Sponsor: Pfizer
Renal Impairment · Healthy
United States
- Phase Ia/Ib Talazoparib + Tazemetostat for mCRPCActive Not Recruiting
Sponsor: Dana-Farber Cancer Institute
Metastatic Prostate Cancer · Metastatic Castration-resistant Prostate Cancer
United States
- A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took Lorlatinib as Their First TreatmentActive Not Recruiting
Sponsor: Pfizer
Non-Small-Cell Lung · ALK-positive Advanced NSCLC · ALK-positive Non-small-cell Lung Cancer · ALK-positive NSCLC
United States
Sponsor: University of Utah
Advanced KRAS Positive Metastatic Colorectal Cancer
United States
- A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world SettingRecruiting
Sponsor: Pfizer
Pneumonia
United States, Israel, Spain
- A Study to Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe Respiratory Syncytial Virus (RSV) DiseaseActive Not Recruiting
Sponsor: Pfizer
Respiratory Syncytial Viruses
United States
Sponsor: University of Southern California
Hematopoietic and Lymphatic System Neoplasm · Malignant Solid Neoplasm
United States
- A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersTerminated
Sponsor: Pfizer
Peripheral T Cell Lymphoma · Diffuse Large B-cell Lymphoma · Classical Hodgkin Lymphoma · Head and Neck Squamous Cell Carcinoma
United States, Spain
Sponsor: David Avigan
Multiple Myeloma · Relapse Multiple Myeloma · Refractory Multiple Myeloma
United States
- Consistency of Response With Rimegepant in Acute Treatment of MigraineActive Not Recruiting
Sponsor: Pfizer
Migraine
United Kingdom
- A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.Active Not Recruiting
Sponsor: Pfizer
Myocarditis
United States
Sponsor: Pfizer
Lyme Disease
United States
Sponsor: Pfizer
ALK+ Non-Small-Cell Lung Carcinoma
France
- PF-07104091 as a Single Agent and in Combination TherapyActive Not Recruiting
Sponsor: Pfizer
Small Cell Lung Cancer · Ovarian Cancer · Breast Cancer
United States, Argentina, Bulgaria, China
Sponsor: Ottawa Heart Institute Research Corporation
Subclinical Atrial Fibrillation
Canada
- SLM + Axitinib for Clear Cell RCCCompleted
Sponsor: Mohammed Milhem
Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)
United States
Sponsor: Pfizer
Diffuse Large B-Cell Lymphoma
United States, Israel, Japan, Turkey (Türkiye)
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)Active Not Recruiting
Sponsor: Pfizer
Breast Cancer
United States, Belgium, France, Italy
Sponsor: Pfizer
Lyme Disease
United States, Canada